Nóticias Cannabicas

Medical News

• What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps? mayo 16, 2022
  Medical use of cannabis has been receiving growing attention over the last few decades in modern medicine. As we know that the endocannabinoid system is largely involved in neurological disorders, we focused on the scientific rationale of medical cannabis in three neurological disorders: amyotrophic lateral sclerosis, Parkinson's disease, and Alzheimer's disease through pharmacological plausibility, clinical […]

  Clémence Lacroix

• Cannabis Vaping Among Youth and Young Adults: a Scoping Review mayo 16, 2022
  PURPOSE OF REVIEW: The purpose of this review was to describe the state-of-the-literature on research specific to cannabis vaping among youth and young adults.

  Melissa B Harrell

• Psychological factors and the use of psychoactive substances in relation to sexual orientation: A study on Israeli young adults mayo 16, 2022
  In the context of sexual minorities and the distress they may experience, recent years have witnessed a trend emphasizing the idea that protective factors may curb risk behaviors, while stressing that not all sexual minorities do experience distress. However, protective factors have been studied less frequently than have risk factors. To the extent that protective […]

  Mally Shechory Bitton

• Hospital epidemiology of psychiatric disorders in Mali mayo 16, 2022
  CONCLUSION: people hospitalised for psychiatric disorders from 2014 to 2018 were predominantly young and male with a history of psychiatric disorders. They mainly had schizophrenia, schizotypic disorders and delusional disorders.

  Souleymane Papa Coulibaly

• Research Trends in Individuals at High Risk for Psychosis: A Bibliometric Analysis mayo 16, 2022
  The study of clinical high risk for psychosis (CHR-P) has progressed rapidly over the last decades and has developed into a significant branch of schizophrenia research. Organizing the information about this rapidly growing subject through bibliometric analysis enables us to gain a better understanding of current research trends and future directions to be pursued. Electronic […]

  Tae Young Lee

• The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review mayo 16, 2022
  Individuals with borderline personality disorder (BPD) or antisocial personality disorder (ASPD) are overrepresented in forensic settings. Yet, despite the burden these disorders place on healthcare and criminal justice systems, there remains a lack of evidence-based pharmacological treatments. Epidemiological data have shown that comorbid cannabis use disorders are common in BPD and ASPD. ∆⁹ -Tetrahydrocannabinol, the […]

  Wilson Ho

• Patterns of Substance Use Disorders and Associated Co-occurring Psychiatric Morbidity among Patients Seen at the Psychiatric Unit of a Tertiary Health Center mayo 16, 2022
  CONCLUSION: Results suggest an association between SUDs and co-occurring mental illness, though differences in these associations were noticed across the categories of substances. This emphasizes a holistic approach to prevention and care of patients presenting with SUDs.

  Adetunji Obadeji

• Validation of the Soleris® NF-TVC Method for Detection of Aerobic, Mesophilic Microorganisms in Dried Cannabis Flower: AOAC Performance Tested MethodSM 071203 mayo 16, 2022
  CONCLUSIONS: It is concluded that the Soleris NF-TVC method is an accurate and effective method for detection of aerobic, mesophilic microorganisms in dried cannabis flower.

  Quynh-Nhi Le

• Validation of the Soleris® Coliform Method for Detection of Coliform Bacteria in Dried Cannabis Flower: AOAC Performance Tested MethodSM 010302 mayo 16, 2022
  CONCLUSIONS: The Soleris Coliform test is an accurate method for detection of coliform bacteria in dried cannabis flower.

  Quynh-Nhi Le

• "Dual use of alcohol and cannabis among college students: A reinforcer pathologies approach." Correction to Reed et al. (2021) mayo 16, 2022
  Reports an error in "Dual use of alcohol and cannabis among college students: A reinforcer pathologies approach" by Gideon P. Naudé, Derek D. Reed, Tyler J. Thornton and Michael Amlung (Experimental and Clinical Psychopharmacology, 2021[Aug], Vol 29[4], 407-417). In the original article, in the Method section under Principal Components Analyses, it reads "We used a […]
• Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review mayo 16, 2022
  No abstract

  Stacy Shoshan

• In Reply mayo 16, 2022
  No abstract

  Angela L Liang

• Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes mayo 16, 2022
  No abstract

  Mishka Terplan

• Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids: A case report mayo 16, 2022
  Contamination of synthetic cannabinoids with toxic coumarin derivatives known as superwarfarins can induce a persistent coagulopathy. In comparison to warfarin, these derivatives have prolonged half-lives and laboratory assays for detection are not readily available in clinical practice. To our knowledge, factor-guided diagnosis of coagulopathy secondary to coumarin-contaminated synthetic cannabinoids has not been described previously. Our […]

  Sterling C Torian

• Critical review on recent trends in cannabinoid determination on cannabis herbal samples: From chromatographic to vibrational spectroscopic techniques mayo 15, 2022
  Cannabis has been at the center of scientific attention for some years now. Since its pharmacological potential has been highlighted, cannabis has become a hot topic in research laboratories, leading to the publication of many scientific studies. Focusing on analytical chemistry, an enormous number of analytical methods for cannabinoid (CNB) determination have been published, involving […]

  Riccardo Deidda